UnitedHealth Group (UNH): Among Stocks Insiders Were Piling Into Recently

We recently published a list of Should You Buy the Dip and Follow Insiders into These 10 Stocks?. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other stocks insiders were piling into recently.

After a turbulent week, stocks began recovering on Monday, with all three major indexes posting gains. The broader market index rose 0.64%, blue-chip stocks gained 0.85%, and the NASDAQ Composite, still in correction territory, closed 0.31% higher.

Early Tuesday, stocks began to decline again as investors focused on the Federal Reserve’s two-day policy meeting starting today. The key announcement for traders will come Wednesday when the Fed announces its interest rate decision, followed by a press conference with Fed Chair Jerome Powell. Since September, the Fed has cut interest rates three times and still, the broader market entered a correction.

Despite uncertainty from President Trump’s shifting tariff policies and geopolitical strategies, some analysts remain optimistic about AI’s future.

“We retain our view that there is more to go in stocks, and we keep our conviction in the long-term opportunities in stocks linked to both the artificial intelligence and power and resources transformational innovations,” UBS chief investment office said in a note Monday, according to CNBC.

Amid turbulence and uncertainty on Wall Street, looking at recent insider trades can provide valuable insights, as executives often have a deeper understanding of their companies. For example, when a CEO or CFO buys company stock, it may indicate strong confidence in the business’s future.

However, insider selling doesn’t always signal a lack of confidence. It could be due to personal financial needs or a desire to diversify investments. These sales are often made through pre-arranged plans, like 10b5-1 plans, to avoid any appearance of improper timing.

While insider activity can be informative, it’s important to consider it alongside the company’s financial health, market trends, and industry developments.

Our Methodology

We used Insider Monkey’s insider trading stock screener to analyze recent trading activities in several popular stocks. For each stock, we noted the number of insiders who recently acquired shares and the company’s market capitalization.

Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

UnitedHealth Group Incorporated (UNH): Among Stocks Insiders Were Piling Into Recently

A senior healthcare professional giving advice to a patient in a clinic.

UnitedHealth Group Incorporated (NYSE:UNH)

Number of Insiders Buying: 1

Market Capitalization: $456.46 billion

UnitedHealth Group Incorporated (NYSE:UNH) is a healthcare company operating in the United States and internationally. The Eden Prairie, Minnesota-based company operates through four segments UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. Its offering includes consumer-oriented health benefit plans for various types of employers, medical plans, children’s health insurance, care delivery, wellness and consumer engagement, software and information products, pharmacy care services, etc. It is considered one of the 10 best strong buy stocks tburight now.

For the full year of 2024, the company disclosed revenues of $400.3 billion, compared to $371.6 billion in 2023. UnitedHealth (NYSE:UNH) reaffirmed the 2025 performance outlook, including revenues of $450 billion to $455 billion, net earnings of $28.15 to $28.65 per share, adjusted net earnings of $29.50 to $30.00 per share and cash flow from operations of $32 billion to $33 billion.

On January 17, one insider acquired $511,575 worth of UnitedHealth shares at a price of $511.58 per share. Year-to-date, the stock declined 1.35% and now trades at $499.02. Over the past 12 months, its shares rose 2.46%.

Twenty-one analysts have given an average “Strong Buy” rating on UnitedHeatlh (NYSE:UNH) stock with a price target of $623.60, according to Stock Analysis. The average price target suggests a 24.97% upside from the latest price.

Overall, UNH ranks 8th on our list of stocks insiders were piling into recently. While we acknowledge the potential of UNH, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires

Disclosure: None. This article is originally published at Insider Monkey.